Follow-up and Analysis of Helicobacter pylori Antibioic Resistance in the South Area of Sichuan Province
The Journal of Infectious Diseases · 2025
DOI: 10.1093/infdis/jiaf402 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Infectious Diseases, 2025. Verfasst von Chunhong Liang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan Province, China. Hauptthemen laut MEDLINE: Helicobacter pylori, Helicobacter Infections, Anti-Bacterial Agents, Drug Resistance, Bacterial. Die Arbeit nennt 33 Literaturangaben. Gefördert von: Health Commission of Sichuan Province.
Abstract (Originalsprache)
Background
The antibiotic resistance rate of Helicobacter pylori (H. pylori) has increased year by year with the widespread use of antibiotics, resulting in reduced efficacy of eradication therapy and increased recurrence rate. We conducted a survey on H. pylori resistance in the South area of Sichuan province to provide guidance for front-line treatments of H. pylori in this area.
Methods
Helicobacter pylori strains were isolated from gastric mucosa specimens obtained from patients with suspected H. pylori infection from the South area of Sichuan province. Antibiotic susceptibility of the strains was determined by disk diffusion method.
Results
Among 373 patients, 323 were from southern Sichuan. H. pylori strains were isolated and cultured from gastric mucosa samples of 304 patients, resulting in an isolation and culture success rate of 81.50%. Metronidazole (MNZ) is the antibiotic with the highest drug resistance rate in the South area of Sichuan province, with a drug resistance rate as high as 98.68%. The resistance rates of amoxicillin and furazolidone were very low, accounting for 0.29% and 0.99%, respectively. However, tetracycline showed no resistance. Single antibiotic resistance accounted for 35.67%, while the resistance to 2 antibiotics was dual resistance, accounting for 34.67%. Dual drug resistance was mainly MNZ and levofloxacin, followed by MNZ and clarithromycin (CLA).
Conclusions
MNZ, levofloxacin, and CLA should be used cautiously in H. pylori eradication therapy in the South area of Sichuan province. If the cultivation results and drug sensitivity test results of the H. pylori strain cannot be obtained, it is recommended to adopt an empirical treatment plan, using the pairwise combinations of amoxicillin, tetracycline, and FZD, especially the combination of amoxicillin and tetracycline.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterology, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan Province, China.
ORCID-Profile: Chunhong Liang, Yuyang Zhou, Ying Li, Mei Xu, Changping Li
Förderung
- Health Commission of Sichuan Province
Zitieren
APA
Liang, C., Zhou, Y., Li, Y., Xu, M., & Li, C. (2025). Follow-up and Analysis of Helicobacter pylori Antibioic Resistance in the South Area of Sichuan Province. The Journal of Infectious Diseases. https://doi.org/10.1093/infdis/jiaf402
Vancouver
Liang C, Zhou Y, Li Y, Xu M, Li C. Follow-up and Analysis of Helicobacter pylori Antibioic Resistance in the South Area of Sichuan Province. The Journal of Infectious Diseases. 2025. doi:10.1093/infdis/jiaf402
BibTeX
@article{Liang2025,
author = {Liang, Chunhong and Zhou, Yuyang and Li, Ying and Xu, Mei and Li, Changping},
title = {Follow-up and Analysis of Helicobacter pylori Antibioic Resistance in the South Area of Sichuan Province},
journal = {The Journal of Infectious Diseases},
year = {2025},
doi = {10.1093/infdis/jiaf402}
}
EUVIMED